EBAA Comments on FDA Guidances
EBAA submitted comments to FDA last week on recent guidances that address HCT/P donor eligibility and recommendations to reduce the risk of HIV, hepatitis B virus and hepatitis C virus […]
Regulatory Alert: FDA Inspectional Focus on Donor Eligibility With Regard to Sepsis
BACKGROUND Several recent FDA inspections of eye banks have resulted in Form FDA 483, Inspectional Observations, for not determining donors to be ineligible with a diagnosis of sepsis. All cited […]
Pride Month: A System Designed to Hate
Dylan TurnerThe Cincinnati Eye Bank Recovery Technician EBAA has long advocated for reducing or eliminating FDA’s 5-year exclusionary period for cornea donation for MSM. Navigating a system that was designed […]
EBAA in the News: Advocates Expect the FDA to Ease Restrictions on Cornea Donation by Gay and Bisexual Men
On Friday, May 26, Medscape published the article, “Advocates Expect the FDA to Ease Restrictions on Cornea Donation by Gay and Bisexual Men.” The article notes EBAA’s longtime support for […]
ALERT: CRITICAL SUPPLY ISSUE: BioRad HIV 1/2 Plus O EIA Assay
On May 5, EBAA alerted the membership about a critical supply issue with the BioRad HIV 1/2 Plus O EIA Assay through an All Member post in The Lens. Two […]
